Pathology of benign prostatic hyperplasia

Prostate

Volumn 45, Issue SUPPL. 9, 2000, Pages 4-14

  Foster, C S ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BAX; PROTEIN BCL X;

AGE; ANATOMY; CELL DIFFERENTIATION; CELL HYPERPLASIA; CELL PROLIFERATION; EMBRYOLOGY; GENE MUTATION; HISTOPATHOLOGY; HUMAN; MORPHOGENESIS; ORGANOGENESIS; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; REVIEW; STEM CELL; EPITHELIUM CELL; GROWTH, DEVELOPMENT AND AGING; MALE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PRENATAL DEVELOPMENT; PROSTATE; SKELETAL MUSCLE; SMOOTH MUSCLE; STROMA CELL;

EPITHELIAL CELLS; HUMANS; MALE; MUSCLE, SKELETAL; MUSCLE, SMOOTH; PROSTATE; PROSTATIC HYPERPLASIA; STROMAL CELLS;

EID: 0033649720     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0045(2000)45:9+<4::AID-PROS3>3.0.CO;2-Q     Document Type: Review

References (90)

1. Light microscopic analysis of the normal human prostate and of benign prostatic hyperplasia
2. Morphometric quantitation of stroma in human benign prostatic hyperplasia
3. Morphometry of the prostate: I. Distribution of tissue components in hyperplastic glands
4. The relative proportion of stromal and epithelial hyperplasia is related to the development of symptomatic benign prostate hyperplasia
5. Percentage area density of epithelial and mesenchymal components in benign prostatic hyperplasia: Comparison of results between single biopsy, multiple biopsies and multiple tissue specimens
6. Quantifying the smooth muscle content of the prostate using double-immunoenzymatic staining and colour assisted image analysis
7. This month is investigative urology: Alpha adrenergic innervation of the prostate: Insights into the pharmacotherapy of BPH
8. Alpha-l-adrenoceptor subtypes in the human prostate
9. Prostatic alpha-l-adrenoceptors and uroselectivity
10. Identification, quantification, and localisation of MRNA for three distinct alpha 1 adrenergic receptor subtypes in human prostate
11. Stereology - A new method to assess normal and pathological growth of the prostate
12. Architectural patterns of high grade prostatic intraepithelial neoplasia
13. Atypical adenomatous hyperplasia of prostate: Morphologic criteria for its distinction from well-differentiated carcinoma
14. Smooth muscle-epithelial interactions in normal and neoplastic prostatic development
15. Immunohistochemistry and in situ hybridization of the androgen receptor in the developing human prostate
16. Developmental estrogenization and prostatic neoplasia
17. Morphologic and endocrine aspects of prostatic function
18. Transforming growth factor beta localisation during mouse prostate morphogenesis and in prostatic growth abnormalities
19. Role of epithelial-mesenchymal interactions in the differentiation and spatial organisation of visceral smooth muscle
20. Growth factors as mediators of androgen action during the development of the male urogenital tract
21. The development of the human prostate gland with reference to the development of other structures at the neck of the urinary bladder
22. Growth of the rat prostate gland is facilitated by the autonomic nervous system
23. Effects of norepinephrine and alpha-1 adrenergic blockers on cultured stromal cells from benign prostatic hyperplasia
24. Normal histology of the prostate
25. The prostate and prostatic urethra: A morphologic synthesis
26. Stercological analysis. An approach to the pathogenesis of benign prostatic hyperplasia
27. Stem cells in prostatic epithelia
28. Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: A stem cell model
29. Multidirectional differentiation in the normal, hyperplastic and neoplastic human prostate: Simultaneous demonstration of cell specific epithelial markers
30. Endocrine-paracrine cell types in the prostate and prostatic adenocarcinomas are postmitotic cells
31. Relation of endocrineparacrine cells to cell proliferation in normal hyperplastic and neoplastic human prostate
32. Basal cell hyperplasia of the prostate
33. Basal cell proliferation in benign prostatic hyperplasia
34. Immunohistochemical investigation in different cytokeratins and vimentin in the prostate from the fetal period up to adulthood and in prostate carcinoma
35. The proliferative function of basal cells in the normal and hyperplastic human prostate
36. Long-term explant culture of normal human prostate
37. Atypical basal cell hyperplasia of the prostate. Immunophenotypic profile and proposed classification of basal cell proliferations
38. Detection of the apoptosis-suppressing oncoprotein bcl-2 in hormone-refractory human prostate cancer
39. Differential expression of 5-alpha-reductase isoenzymes in the human prostate and prostatic carcinomas
40. Bcl-2 protein is topographically restricted to tissues characterised by apoptotic cell death
41. Bcl-2: Role in epithelial differentiation and oncogenesis
42. Bcl-x(S) anatagonises the protective effects of Bcl-x(L)
43. Bcl-x(L) forms an ion channel in synthetic lipid membranes
44. The apoptosis-associated gamma-ray response of BclxL depends on normal p53 function
45. Benign nodular hyperplasia of the prostate: A review
46. Morphological classification and comparison of the different types of stromal nodules in benign prostatic hyperplasia
47. Modern considerations and investigations in benign prostatic hyperplasia (BPH)
48. Morphologic and regulatory aspects of prostatic function
49. Benign prostatic hyperplasia: Mechanisms and hypotheses
50. Current, aspects on morphology and functions of the prostate
51. Prostatic stromal cell phenotype is directly modulated by norepinephrine
52. 1-adrenergic antagonist, doxazosin, upon noradrenaline-induced modulation of cytoskeletal proteins in cultured hyperplastic prostatic stromal cells
53. Modulating effect of estrogen and testosterone on prostatic stromal cell phenotype differentiation induced by noradrenaline and doxazosin
54. Benign prostatic hyperplasia
55. Pathogenesis and medical management of benign prostatic hyperplasia
56. Role of peptide growth factors in the prostate - A review
57. Benign prostatic hyperplasia
58. Expression of oestrogen receptor in diseased human prostate assessed by non-radioactive in situ hybridisation and immunohistochemistry
59. Androgen, oestrogen, and progesterone receptors in normal and ageing prostates
60. TRH: Mediator of prolactin in the prostate?
61. Effects of hormones on the prostate in adult and ageing men and animals
62. Effects of oestrogen deprivation on human benign prostatic hyperplasia
63. Characteristics of FGF-receptors expressed by stromal and epithelial cells cultured from normal and hyperplastic prostates
64. Basic fibroblast growth factor in human prostate cancer cells
65. Normal and abnormal development of the male urogenital tract. Role of androgens, mesenchymal-epithelial interactions and growth factors
66. Platelet derived growth factor (PDGF), androgens and inflammation: Possible etiologic factors in the development of prostatic hyperplasia
67. An immunocytochemical analysis of TGF-alpha expression in benign and malignant prostatic tumors
68. Epidermal growth factor and transforming growth factor alpha concentrations in BPH and cancer of the prostate: Their relationships with tissue androgen levels
69. Studies on the proliferation, secretory activities and epidermal growth factor receptor expression in benign prostatic hyperplasia explant cultures
70. Influence of transforming growth factor beta 1 and other growth factors on basic fibroblast growth factor, level, and proliferation of cultured human prostate-derived fibroblasts
71. Regional concentration of basic fibroblast growth factors in normal and benign hyperplastic human prostates
72. Review of peptide growth factors in benign prostatic hyperplasia and urological malignancy
73. Growth factors: Regulation of normal and neoplastic growth
74. Benign prostatic hyperplasia
75. Characterisation of growth factors derived from the rat ventral prostate
76. Heparin binding growth factor isolated from human prostatic extracts
77. Comparative analysis of growth factors in normal and pathologic human prostrates
78. Cloning of two novel forms of human acidic fibroblast growth factor (AFGF) MRNA
79. Heparin-binding growth factor gene expression and receptor characteristics in normal rat prostate and two transplantable rat prostate tumours
80. Basic fibroblast growth factor. A potential mediator of stromal growth in the human prostate
81. Structural characterisation and biological functions of fibroblast growth factor
82. Differential expression of acidic and basic fibroblast growth factors in benign prostatic hyperplasia identified by immunohistochemistry
83. The cellular and molecular basis of prostate cancer